This website is intended for healthcare professionals only
Specialities

Specialities

Artificial Intelligence
Anterior Segment
Cataract Surgery
Corneal and External Disorders
COVID-19
Diabetic Macular Edema
Diabetic Retinopathy
Glaucoma
Imaging
Macular Degeneration
Neuro-ophthalmology
Ocular Oncology
Ocular Surface Disease
Oculoplastic Surgery
Pediatric Ophthalmology
Refractive Surgery
Retina/Vitreous
Ocular Immunology
Rare Disease Day
Posterior Segment
Search

Trending Topic

Macro shot of eye featuring holographic HUD graphics layered over pupil and cornea, neon light accents and sharp reflections, high tech cyber vision theme, ultra detailed 8k
7 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Advancing Keratoconus Management: ECO-CAIRS, Biomechanics and the Evolution of Corneal Allogenic Intrastromal Ring Segments

Emilio A Torres-Netto, Mark Hillen, Farhad Hafezi

Corneal ectatic disorders, such as keratoconus, progressively weaken corneal integrity, leading to thinning, irregular astigmatism and visual deterioration.1 Typically progressive in nature, these ectasias result in increasingly thinner corneas, causing the cornea to protrude forward into a cone shape. This leads to increasing amounts of myopia and astigmatism – both regular and irregular – as the disease […]

touchREVIEWS in Ophthalmology. 2026;20(1):1–4:Online ahead of journal publication

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin

Basil K Williams, Hawaiian Eye 2022: Ocular Oncology – What’s New?

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Feb 8th 2022

The field of ocular oncology is rapidly changing, according to a presentation at Hawaiian Eye 2022. We were delighted to speak with Dr Basil K Williams (University of Cincinnati, Cincinnati, OH, USA) about new developments in the field of ocular oncology.

The abstract entitled What’s New in the World of Ocular Oncology? was presented at Hawaiian Eye 2022, 15–21 January 2022.  

Questions

  1. Could you give us a brief overview of the field of ocular oncology? (00:20)
  2. What has been the impact of anterior segment optical coherence tomography on diagnosis and clinical examination? (01:00)

Speaker Disclosure: Basil K Williams is a consultant for Allergan, Castle Biosciences and Genentech.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.

Filmed in coverage of Hawaiian Eye 2022.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

ARVO 2026: AI model demonstrates high accuracy in retinoblastoma detection

Swathi Kaliki

Artificial intelligence was a major theme throughout the ARVO 2026 Annual Meeting, with growing interest in how AI-driven tools could support earlier diagnosis, improve clinical decision-making and expand access to specialist care. In the session AI Developments in Ocular Oncology and Ophthalmic Pathology, Dr Swathi Kaliki (OEU Institute for Eye Cancer, LV Prasad Eye Institute) explored the evolving role of artificial intelligence and machine learning in retinoblastoma screening and classification.

Advertisement

    • Related Videos in Ocular Oncology

    Latest articles videos and clinical updates - straight to your inbox

    Close Popup